FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2979639473> ?p ?o ?g. }

• W2979639473 endingPage "8208" @default.
• W2979639473 startingPage "8195" @default.
• W2979639473 abstract "Zinc oxide nanoparticles (ZnO NPs) are used in modern cancer therapy based on their specific target, efficacy, low toxicity and biocompatibility. The photocatalytic performance of Zinc oxide (ZnO) nanocomposites with hyaluronic acid (HA) was used to study anticancer properties against various human cancer cell lines.Zinc oxide (ZnO) nanocomposites functionalized by hyaluronic acid (HA) were prepared by a co-precipitation method (HA-ZnONcs). The submicron-flower-shaped nanocomposites were further functionalized with ginsenoside Rh2 by a cleavable ester bond via carbodiimide chemistry to form Rh2HAZnO. The physicochemical behaviors of the synthesized ZnO nanocomposites were characterized by various analytical and spectroscopic techniques. We carried out 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay to evaluate the toxicity of Rh2HAZnO in various human cancer cells (A549, MCF-7, and HT29). Furthermore, to confirm the apoptotic effects of Rh2HAZnO and to determine the role of the Caspase-9/p38 MAPK pathways by various molecular techniques such as RT-PCR and Western blotting. Furthermore, Rh2HAZnO induced morphological changes of these cell lines, mainly intracellular reactive oxygen species (ROS) were observed by ROS staining and nucleus by Hoechst staining.We confirmed that Rh2HAZnO exhibits the anti-cancer effects on A549 lung cancer, HT29 colon cancer, and MCF7 breast cancer cells. Moreover, intracellular reactive oxygen species (ROS) were observed in three cancer cell lines. Rh2HAZnO induced apoptotic process through p53-mediated pathway by upregulating p53 and BAX and downregulating BCL2. Specifically, Rh2HAZnO induced activation of cleaved PARP (Asp214) in A549 lung cancer cells and upregulated Caspase-9/phosphorylation of p38 MAPK in other cell lines (HT29 and MCF-7). Furthermore, Rh2HAZnO induced morphological changes in the nucleus of these cell lines.These results suggest that the potential anticancer activity of novel Rh2HAZnO nanoparticles might be linked to induction of apoptosis through the generation of ROS by activation of the Caspase-9/p38 MAPK pathway." @default.
• W2979639473 created "2019-10-18" @default.
• W2979639473 creator A5022520248 @default.
• W2979639473 creator A5023564935 @default.
• W2979639473 creator A5040513207 @default.
• W2979639473 creator A5066523909 @default.
• W2979639473 creator A5069167592 @default.
• W2979639473 creator A5071010370 @default.
• W2979639473 creator A5076134543 @default.
• W2979639473 creator A5080788434 @default.
• W2979639473 creator A5082836093 @default.
• W2979639473 date "2019-10-01" @default.
• W2979639473 modified "2023-10-12" @default.
• W2979639473 title "<p>Photoluminescent And Self-Assembled Hyaluronic Acid-Zinc Oxide-Ginsenoside Rh2 Nanoparticles And Their Potential Caspase-9 Apoptotic Mechanism Towards Cancer Cell Lines</p>" @default.
• W2979639473 cites W1943670532 @default.
• W2979639473 cites W1987549149 @default.
• W2979639473 cites W1990681348 @default.
• W2979639473 cites W1991455654 @default.
• W2979639473 cites W2007185373 @default.
• W2979639473 cites W2014791074 @default.
• W2979639473 cites W2034891521 @default.
• W2979639473 cites W2037003766 @default.
• W2979639473 cites W2062014088 @default.
• W2979639473 cites W2062289724 @default.
• W2979639473 cites W2076353578 @default.
• W2979639473 cites W2077845139 @default.
• W2979639473 cites W2081482599 @default.
• W2979639473 cites W2096482056 @default.
• W2979639473 cites W2100550784 @default.
• W2979639473 cites W2126262424 @default.
• W2979639473 cites W2141071219 @default.
• W2979639473 cites W2147157289 @default.
• W2979639473 cites W2253181543 @default.
• W2979639473 cites W2410762171 @default.
• W2979639473 cites W2437719412 @default.
• W2979639473 cites W2500695738 @default.
• W2979639473 cites W2523360988 @default.
• W2979639473 cites W2589763318 @default.
• W2979639473 cites W2608723816 @default.
• W2979639473 cites W2765293097 @default.
• W2979639473 cites W2770749640 @default.
• W2979639473 cites W2777643352 @default.
• W2979639473 cites W2797428900 @default.
• W2979639473 cites W2902942234 @default.
• W2979639473 cites W2912240897 @default.
• W2979639473 cites W4292404968 @default.
• W2979639473 cites W47224008 @default.
• W2979639473 doi "https://doi.org/10.2147/ijn.s221328" @default.
• W2979639473 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6790350" @default.
• W2979639473 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31632027" @default.
• W2979639473 hasPublicationYear "2019" @default.
• W2979639473 type Work @default.
• W2979639473 sameAs 2979639473 @default.
• W2979639473 citedByCount "35" @default.
• W2979639473 countsByYear W29796394732019 @default.
• W2979639473 countsByYear W29796394732020 @default.
• W2979639473 countsByYear W29796394732021 @default.
• W2979639473 countsByYear W29796394732022 @default.
• W2979639473 countsByYear W29796394732023 @default.
• W2979639473 crossrefType "journal-article" @default.
• W2979639473 hasAuthorship W2979639473A5022520248 @default.
• W2979639473 hasAuthorship W2979639473A5023564935 @default.
• W2979639473 hasAuthorship W2979639473A5040513207 @default.
• W2979639473 hasAuthorship W2979639473A5066523909 @default.
• W2979639473 hasAuthorship W2979639473A5069167592 @default.
• W2979639473 hasAuthorship W2979639473A5071010370 @default.
• W2979639473 hasAuthorship W2979639473A5076134543 @default.
• W2979639473 hasAuthorship W2979639473A5080788434 @default.
• W2979639473 hasAuthorship W2979639473A5082836093 @default.
• W2979639473 hasBestOaLocation W29796394731 @default.
• W2979639473 hasConcept C121608353 @default.
• W2979639473 hasConcept C12554922 @default.
• W2979639473 hasConcept C153911025 @default.
• W2979639473 hasConcept C185592680 @default.
• W2979639473 hasConcept C190283241 @default.
• W2979639473 hasConcept C192562407 @default.
• W2979639473 hasConcept C2780783641 @default.
• W2979639473 hasConcept C48349386 @default.
• W2979639473 hasConcept C502942594 @default.
• W2979639473 hasConcept C54355233 @default.
• W2979639473 hasConcept C55493867 @default.
• W2979639473 hasConcept C81729549 @default.
• W2979639473 hasConcept C86803240 @default.
• W2979639473 hasConcept C96232424 @default.
• W2979639473 hasConceptScore W2979639473C121608353 @default.
• W2979639473 hasConceptScore W2979639473C12554922 @default.
• W2979639473 hasConceptScore W2979639473C153911025 @default.
• W2979639473 hasConceptScore W2979639473C185592680 @default.
• W2979639473 hasConceptScore W2979639473C190283241 @default.
• W2979639473 hasConceptScore W2979639473C192562407 @default.
• W2979639473 hasConceptScore W2979639473C2780783641 @default.
• W2979639473 hasConceptScore W2979639473C48349386 @default.
• W2979639473 hasConceptScore W2979639473C502942594 @default.
• W2979639473 hasConceptScore W2979639473C54355233 @default.
• W2979639473 hasConceptScore W2979639473C55493867 @default.
• W2979639473 hasConceptScore W2979639473C81729549 @default.
• W2979639473 hasConceptScore W2979639473C86803240 @default.
• W2979639473 hasConceptScore W2979639473C96232424 @default.

• next